Cabaletta Bio, Inc. (CABA)
2.92
-0.22
(-7.01%)
USD |
NASDAQ |
Feb 20, 14:44
Cabaletta Bio Market Cap : 281.09M for Feb. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Anavex Life Sciences Corp. | 380.88M |
| CorMedix, Inc. | 555.46M |
| Verastem, Inc. | 448.91M |
| Ocugen, Inc. | 528.62M |
| AnaptysBio, Inc. | 1.520B |
Market Cap Related Metrics
| PEG Ratio | -0.0671 |
| Price to Book Value | 2.016 |
| Price | 2.92 |
| Earnings Yield | -86.52% |
| PEGY Ratio | -0.0671 |